Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

about

Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

Item

http://www.wikidata.org/entity/Q55174270

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

@en

Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

@nl

type

Item

label

Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

@en

Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

@nl

prefLabel

Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

@en

Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

@nl

P1476

Challenges in cerebrospinal fluid shunting in patients with glioblastoma

@en

P2093

Christian Hartmann

http://www.w3.org/2001/XMLSchema#string

Hans E Heissler

http://www.w3.org/2001/XMLSchema#string

Joachim K Krauss

http://www.w3.org/2001/XMLSchema#string

Makoto Nakamura

http://www.w3.org/2001/XMLSchema#string

Manolis Polemikos

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Frequency and long-term follow-up of trapped fourth ventricle following neonatal posthemorrhagic hydrocephalus.

The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis

Brain edema in neurooncology: radiological assessment and management.

Thalamic glioblastoma with cerebrospinal fluid dissemination in the peritoneal cavity.

Immune defects observed in patients with primary malignant brain tumors.

Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel® implantation--incidence, therapeutic strategies, and outcome.

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide

P2888

s12987-018-0101-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12987-018-0101-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bujung Hong

P577

2018-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104022473

http://www.w3.org/2001/XMLSchema#string

P698

29860942

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

5985574

http://www.w3.org/2001/XMLSchema#string